Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.
- DOI
- 10.1016/s1473-3099(23)00519-4
- Published
- 2024 Mar
- Container
- The Lancet. Infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-23-00519-4,
title = {Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.},
author = {Rivera Mejía L and Peña Méndez L and Bandyopadhyay AS and Gast C and Mazara S and Rodriguez K and Rosario N and Zhang Y and Mainou BA and Jimeno J and Aguirre G and Rüttimann R},
year = {2024},
journal = {The Lancet. Infectious diseases},
doi = {10.1016/s1473-3099(23)00519-4},
url = {https://doi.org/10.1016/s1473-3099(23)00519-4}
}RIS
TY - JOUR TI - Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic. AU - Rivera Mejía L AU - Peña Méndez L AU - Bandyopadhyay AS AU - Gast C AU - Mazara S AU - Rodriguez K AU - Rosario N AU - Zhang Y AU - Mainou BA AU - Jimeno J AU - Aguirre G AU - Rüttimann R PY - 2024 JO - The Lancet. Infectious diseases DO - 10.1016/s1473-3099(23)00519-4 UR - https://doi.org/10.1016/s1473-3099(23)00519-4 ER -
APA
L, R. M., L, P. M., AS, B., C, G., S, M., K, R., N, R., Y, Z., BA, M., J, J., G, A., & R, R. (2024). Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(23)00519-4
Source records
- pubmed · retrieved 2026-09-26T12:29:26.209Z
- europe-pmc · retrieved 2026-09-26T12:29:26.209Z